DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA?
- 1 June 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 329 (8547) , 1402-1405
- https://doi.org/10.1016/s0140-6736(87)90594-0
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused geneCell, 1986
- T-Cell Acute Lymphoblastic Leukemias with a t(8;14) Possibly Involving a c-mycLocus and T-Cell–Receptor α-Chain GenesNew England Journal of Medicine, 1986
- Genomic diversity correlates with clinical variation in Ph′-negative chronic myeloid leukaemiaNature, 1986
- bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.The Journal of Experimental Medicine, 1985
- Philadelphia chromosome‐negative chronic myelogenous leukaemia: a morphological reassessmentBritish Journal of Haematology, 1985
- Structural organization of the bcr gene and its role in the Ph′ translocationNature, 1985
- Fused transcript of abl and bcr genes in chronic myelogenous leukaemiaNature, 1985
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Assignment of the haemophilia B (Factor IX) locus to the q26‐qter region of the X chromosomeAnnals of Human Genetics, 1984
- Localization of single copy DNA sequences on G-banded human chromosomes by in situ hybridizationChromosoma, 1981